Last reviewed · How we verify

NCT00997893: RISE

Effects of Estradiol and Soy on Menopausal Symptoms

Completed Phase 2 Results posted Last updated 12 November 2020
What this trial tests

Phase 2 trial testing Soy Phytoestrogen in Menopause in 96 participants. Completed in 1 May 2015.

Timeline
1 December 2009
Primary endpoint
1 May 2015
1 May 2015

Quick facts

Lead sponsorUniversity of Illinois at Chicago
PhasePhase 2
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposetreatment
Enrollment96
Start date1 December 2009
Primary completion1 May 2015
Estimated completion1 May 2015
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

University of Illinois at Chicago

Who can join

Adults 40 to 65, female only, with Menopause or Hot Flashes. Patients with the condition only — healthy volunteers not accepted.

What's being measured

Primary outcomes are the specific endpoints the trial is designed to prove or disprove.

Sponsor's own description

The purpose of this study is to determine the effects of oral estradiol and soy phytoestrogens on anxiety, stress responsivity and cognition in perimenopausal women.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Menopause

Currently open trials in the same condition.

Other University of Illinois at Chicago trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT00997893.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing